| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Corbus Pharmaceuticals Holdings Inc is a clinical stage company focused on new therapies in oncology and obesity and is committed to helping people defeat serious illness by bringing inventive scientific approaches to well-understood biological...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Corbus Pharmaceuticals (NASDAQ:CRBP) through any online brokerage.
Other companies in Corbus Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Corbus Pharmaceuticals has a consensus price target of $42.55.
The stock price for Corbus Pharmaceuticals (NASDAQ: CRBP) is $4.32 last updated October 22, 2026 at 9:30 AM EDT.
There are no upcoming dividends for Corbus Pharmaceuticals.
Corbus Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Corbus Pharmaceuticals.
Corbus Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
